Bernardo Chua Gives Quality Coffee at Organo Gold

Bernardo Chua is the CEO of Organo Gold. His specialty in entrepreneurship is direct sales, a strategy that he believes works so well and that has seen him excel. Direct sales have seen his line of business develop each day. Organo Gold is a coffee company, it also makes other products that are close to coffee.

He also has expertise in network marketing, a skill he has used to boost the development of Organo Gold. Moreover he is a beneficiary of the Napoleon Hill Foundation Gold Medal.

Everyone can be an entrepreneur but it takes the best entrepreneurs to receive awards due to their hard work. Bernardo Chua has received these awards, they are Dangal ng Bayan by people’s Choice Awards and in 2014 he got the National Consumers Quality Award.

The company has been mentioned as part of direct selling firms in the food supply sector. In matters of a worldwide situation, Chua has partnered with important people in Ganoderma creation.

He has an experience of so many years when it comes to direct sales business and letting people know how important it is to the business economy. Due to his success he has extended his business to The Philippines. Ganoderma is the main produce in Organo Gold. It is an extraordinary ingredient which produces mushrooms. Bernado Chua had knowledge of the ingredient.

In 2006 the organization was mentioned as the 55th biggest direct sales company globally, this is because of how prosperous it has become thus marking its success. It achieved this accomplished because in a couple of 5 years it showed so much development. The company has one million suppliers around the world.

Organo Gold has been sustainable in producing worthy coffee worldwide and therefore boosting its work in the industry. The organization has excellent products that maintain the relationship it has with its clients as well as the business development.

This coffee the company produces is nourishing and has a good flavor. Organo Gold is situated in Canada, this is a country that is well-known to have great strategies in producers and businesses, therefore the company is in good hands.

Learn more about Bernardo Chua: http://www.zoominfo.com/p/Bernardo-Chua/676218748

Mikhail Blagosklonny and his works at Roswell Park Cancer Institute

Mikhail Blagosklonny is the current Professor of Oncology at the Institute of Roswell Park of Cancer located in Buffalo. The institute is one of the few comprehensive cancer treatment institutions located in New York. Before being appointed to the school, he was a teacher at the New York Medical College. He was also a researcher on Nature at the Ordway Research Institute located in Albany. Before coming to the United States, Dr. Blagosklonny did his medical education at the Pavlov Medical University located in St. Petersburg in Russia. He later advanced his education and completed a Ph.D. in experimentation medicine within the same institution.

Mikhail Blagosklonny has made several contributions to the field of oncology. He has focused his experimental skills and intellect to look for treatment in aging and cancer that offer long-term solutions. His concern has been to find a cure that can kill infected cancer cells. The treatment should not interfere the healthier cells during the entire process. Mikhail Blagosklonny has researched to understand how the anti-aging medication functions. He wants to create an effective solution to the problem of getting old.

Blagosklonny is popular for the formation of a hypothesis surrounding TOR signal in cancer and aging. He proposed the use of Rapamycin enzyme, a traditional enzyme and drug, to treat life extension. He has researched deeply on the use of Rapamycin. His level of research on LinkedIn has seen him become one of the world’s most passionate researcher in Rapamycin and its anti-aging results. Blagosklonny is the chief editor of several publications. He has authored Oncotarget, Cell Cycle, Aging and other publications. He is also an associate editor of a journal known as Cancer Therapy and Biology. He is a member of the editorial team that handles Cell Differentiation and Death.

Mikhail is popular for the aging hyperfunction theory. He has focused on writing about chemotherapeutic engineering on tandfonline.com. Mikhail’s interest in cancer and oncology has seen him believe that there is a treatment for cancer. He has written over 300 research articles on Google that focus on the issue. He has grown to become one of the biggest Oncology Researchers known in the world today. He has shown a deep love for humanity and a strong vision to create a world that is disease-free.